Recurrence and Progression of T1G3 Transitional Cell Carcinoma of the Bladder Treated with Intravesical Bacillus Calmette-Guérin

Publisher： Karger

E-ISSN： 1423-0399|75|2|107-113

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.75, Iss.2, 2008-07, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical Bacillus Calmette-Guérin Therapy for T1 Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 1, 2008-01 ,pp. : 74-79

Karger

Access to resources Recommend Favorite

Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high‐risk non‐muscle‐invasive bladder cancer treated with maintenance intravesical Bacillus Calmette‐Guérin

By  

BJU INTERNATIONAL, Vol. 116, Iss. 5, 2015-11 ,pp. : 721-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high‐risk non‐muscle‐invasive bladder cancer treated with maintenance intravesical Bacillus Calmette‐Guérin

By  

BJU INTERNATIONAL, Vol. 1464-4096, Iss. 5, 2015-11 ,pp. : 721-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer

By  

Urologia Internationalis, Vol. 96, Iss. 2, 2016-0 ,pp. : 136-141

Karger

Access to resources Recommend Favorite

Intravesical Gemcitabine in BCG-Refractory T1G3 Transitional Cell Carcinoma of the Bladder: A Pilot Study

By  

Urologia Internationalis, Vol. 76, Iss. 2, 2006-02 ,pp. : 106-111

Karger

Access to resources Recommend Favorite